← All companies
Hold Current rating · 2 reports
Hold Recap: Q2 2026
Merck Carried the Quarter, Tempus Carries the Stock: A 30% Beat With Flat First-Half Revenue Underneath
Hold Recap: Q1 2026
Clinical Adoption Is Working; Reimbursement Still Has to Pay for It
The depth and quality Wall Street pays for — free.
Missed the earnings call? Don't miss our breakdown.